Market Closed - Nasdaq 04:00:00 2024-04-26 pm EDT 5-day change 1st Jan Change
9.96 USD +3.97% Intraday chart for AdaptHealth Corp. +6.64% +36.63%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
AdaptHealth Names Suzanne Foster as CEO MT
AdaptHealth Names Suzanne Foster CEO DJ
AdaptHealth Corp. Announces Chief Executive Officer Changes CI
AdaptHealth Corp. Announces Richard Barasch Steps Down as Chairman of the Board, Effective June 30, 2024 CI
Health Care Down as Viking Move Rattles Novo Shares -- Health Care Roundup DJ
AdaptHealth's Q4 Loss Widens, Revenue Rises; Provides 2024 Revenue Guidance; Shares Climb MT
Transcript : AdaptHealth Corp., Q4 2023 Earnings Call, Feb 27, 2024
AdaptHealth Corp. Provides Earnings Guidance for the Fiscal Year 2024 CI
AdaptHealth Corp. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
Earnings Flash (AHCO) ADAPTHEALTH Posts Q4 Revenue $858.2M, vs. Street Est of $825.5M MT
AdaptHealth Corp. Announces Goodwill Impairment Charges for the Quarter Ended December 31, 2023 CI
North American Morning Briefing : Stock Futures Pause as Investors Eye Inflation Data DJ
One Equity Partners appoints Belinfanti as new president RE
Transcript : AdaptHealth Corp. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 05:15 PM
Transcript : AdaptHealth Corp. Presents at Bank of America Virtual Home Care Conference 2023, Dec-05-2023 01:20 PM
North American Morning Briefing : Traders Await -2- DJ
AdaptHealth Facing Headwinds Due to Slower-Than-Expected Patient Transitions, BofA Says MT
Transcript : AdaptHealth Corp., Q3 2023 Earnings Call, Nov 07, 2023
Earnings Flash (AHCO) ADAPTHEALTH Reports Q3 Revenue $804M, vs. Street Est of $796.6M MT
Tranche Update on AdaptHealth Corp.'s Equity Buyback Plan announced on May 10, 2022. CI
AdaptHealth Corp. Reports Unaudited Consolidated Impairment Charges Results for the Third Quarter Ended September 30, 2023 CI
AdaptHealth Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Adapthealth Corp. Updates Revenue Guidance for the Year 2023 CI
AdaptHealth Chief Executive Officer Steps Down MT
AdaptHealth says terminated appointment contract for incoming CEO RE
Chart AdaptHealth Corp.
More charts
Adapthealth Corp. provides patient-centered, healthcare-at-home solutions, including home medical equipment (HME), medical supplies and related services. The Company is primarily focused on providing sleep therapy equipment, supplies and related services, including CPAP and bi PAP services to individuals suffering from obstructive sleep apnea (OSA); medical devices and supplies to patients for the treatment of diabetes, including continuous glucose monitors (CGM) and insulin pumps; home medical equipment to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs. The Company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. It serves patients annually in all 50 states through its network of approximately 680 locations in 47 states.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
9.96 USD
Average target price
11.85 USD
Spread / Average Target
+18.98%
Consensus
  1. Stock Market
  2. Equities
  3. AHCO Stock
  4. News AdaptHealth Corp.
  5. Earnings Flash (AHCO) ADAPTHEALTH Reports Q2 Revenue $793.3M, vs. Street Est of $765.2M